Sign in

CIK 0001075880 · Non-accelerated filer

KAZIA THERAPEUTICS LTD

Sign in to watch
Ticker
KZIA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
Australia
Entity type
operating
Phone
01161298780088
Business address
THREE INTERNATIONAL TOWERS LEVEL 24,, 300 BARANGAROO AVENUE, SYDNEY NSW, Australia, 2000
Former names
NOVOGEN LTD
  1. 424B3 Offering Prospectus
  2. 424B3 Offering Prospectus
  3. 424B3 Offering Prospectus
  4. 424B3 Offering Prospectus
  5. 6-K Event Report of Foreign Issuer
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. EFFECT Other Notice of Effectiveness
  8. EFFECT Other Notice of Effectiveness
  9. 424B3 Offering Prospectus
  10. 424B3 Offering Prospectus
  11. 424B3 Offering Prospectus
  12. 424B3 Offering Prospectus
  13. EFFECT Other Notice of Effectiveness
  14. EFFECT Other Notice of Effectiveness
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. POS AM Other Post-effective Amendment for Registration Statement
  18. POS AM Other Post-effective Amendment for Registration Statement
  19. F-1/A Offering Registration Statement for Certain Foreign Private Issuers
  20. F-1 Offering Registration Statement for Certain Foreign Private Issuers

Page 6 of 60 · 1,191 filings